학술논문
Analysis of East Asia subgroup in Study 309/KEYNOTE-775: lenvatinib plus pembrolizumab versus treatment of physician’s choice chemotherapy in patients with previously treated advanced or recurrent endometrial cancer
Document Type
Article
Author
Source
In: Journal of Gynecologic Oncology . (Journal of Gynecologic Oncology, Mar 2024, 35(2))
Subject
Language
English
ISSN
20050399
20050380
20050380